Carcinoma: all 6,719 studies
Page 66 of 68. Open to participants first (1,142), then studies with results posted, then the rest; newest registration first within each.
- Iressa (ZD1839) Plus Anastrozole (Arimidex) in Patients With Ovarian CancerCompletedNCT00181688Phase 2
- Valproic Acid in the Induction of EBV Lytic Cycle Antigen Expression in Nasopharyngeal CarcinomaWithdrawnNCT00181220Phase 1
- Analgesia of Fibula Free Flap Donor Site by Peri-Neuronal Catheter in Oro-Pharyngeal Carcinoma SurgeryStatus unknownNCT00181038Phase 3
- PHASE III TRIAL COMPARING, NEOADJUVANT CHEMOTHERAPY FOLLOWED BY STANDARD RADIOTHERAPY VERSUS THE SAME NEOADJUVANT CHEMOTHERAPY FOLLOWED BY STANDARD RADIOTHERAPY ASSOCIATED WITH DAILY HYDROXYUREA IN THE TREATMENT OF LOCALLY ADVANCED UNDIFFERENTIATED CARCINOMA NASOPHARYNGEAL TYPE.Status unknownNCT00180973Phase 3
- Study of Imatinib (Glivec) in Patients With Adenoid Cystic Carcinoma of the Head and NeckStatus unknownNCT00180921Phase 2
- Yoga-Based Rehabilitation Program in Reducing Physical and Emotional Side Effects in Patients With CancerCompletedNCT00179348Not applicable
- A National Registry of Patients With Hepatocellular CarcinomaCompletedNCT00178867
- Irinotecan, 5-Fluorouracil, and Leucovorin in Colorectal CarcinomaCompletedNCT00176774Phase 2
- Randomized Phase 2 Trial of Pre-chemotherapy Leukine vs. Leukine-Dexamethasone in Combination With Gemzar & 5-FU in Patients With Metastatic Renal Cell CarcinomaWithdrawnNCT00176280Phase 2
- Paclitaxel, Carboplatin And Low Dose Radiation As Induction Therapy In Locally Advanced Head And Neck CancerCompletedNCT00176267Phase 2
- Gemcitabine and Ifosfamide As a Second-Line Systemic Chemotherapy for Cisplatin -Failed Advanced TCCCompletedNCT00173862Phase 2
- PTEN and IGFBP-3 Correlation in Ovarian Carcinoma InvasionWithdrawnNCT00173407Not applicable
- Genetic Studies in Liver Cancer PatientsStatus unknownNCT00172640
- Chemoprevention Trial for Uremia-Associated Urothelial CarcinomaWithdrawnNCT00172367Phase 2
- A Phase II/III Clinical Study on Inhibitory Effects of E0167 on Recurrence of Hepatocellular CarcinomaTerminatedNCT00165633Phase 2/3
- Bevacizumab in Advanced Hepatocellular CarcinomaStatus unknownNCT00162669Phase 2
- Patient Selection for Hypoxia Modifying Treatments in Larynx CarcinomasCompletedNCT00160095
- Radiotherapy Plus Thalidomide in Locally Advanced Hepatocellular CarcinomaStatus unknownNCT00155272Phase 1/2
- Molecular Mechanism of Nasopharyngeal CarcinomaStatus unknownNCT00155181
- Effect of Polymorphisms in the IL-1 Gene Complex on the Development of Chronic Hepatitis and Hepatocellular CarcinomaStatus unknownNCT00155103
- IGFBP-3 in Ovarian Cancer InvasionStatus unknownNCT00154986Not applicable
- A Phase II Study of Radiotherapy for Locally Advanced Hepatocellular Carcinoma (HCC)CompletedNCT00154817Phase 2
- Searching for the Liver Cancer-Related BiomarkersStatus unknownNCT00154544
- Identification of Biomarkers Associated With Human Hepatocellular Carcinoma by SELDIStatus unknownNCT00154531
- WT1 Peptid Vaccination in CarcinomasStatus unknownNCT00153608Phase 2
- Efficacy of Activated Lymphocytes in Renal Cell Carcinoma.TerminatedNCT00151645Phase 2
- Phase Ⅲ Randomized Trial in Postoperative Hepatocellular CarcinomaCompletedNCT00149565Phase 3
- Clinical Evaluation of a New Highly Sensitive Thyroglobulin Assay in Differentiated Thyroid CarcinomaCompletedNCT00148213
- Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary SiteTerminatedNCT00148135Phase 2
- Randomized Trial of ARCON in Larynx CancerCompletedNCT00147732Phase 3
- Adjuvant Versus Progression-Triggered Gemcitabine Monotherapy for Locally Advanced Bladder CancerStatus unknownNCT00146276Phase 3
- Multicenter Study Differentiated Thyroid CarcinomaCompletedNCT00144079Phase 3
- Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular CarcinomaCompletedNCT00142467Phase 2
- Cetuximab in Patients With Unresectable or Metastatic Hepatocellular CarcinomaCompletedNCT00142428Phase 2
- Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and NeckCompletedNCT00139269Phase 1/2
- Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and NeckCompletedNCT00139243Phase 1/2
- Combination Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and NeckCompletedNCT00139230Phase 2
- Study of Motexafin Gadolinium for the Treatment of Renal Cell (Kidney) CancerCompletedNCT00134186Phase 2
- Treatment Use Study With Sunitinib (SU011248) For Patients With Cytokine-Refractory Metastatic Renal Cell CarcinomaApproved for marketingNCT00130897
- A Study to Evaluate the Effectiveness of Imiquimod 5% Cream for Basal Cell Carcinoma RecurrenceCompletedNCT00129519Phase 3
- Oxaliplatin With Gemcitabine in Patients With Carcinoma of the Urothelial TractTerminatedNCT00127595Phase 2
- Trastuzumab in Treating Patients With Metastatic or Recurrent Salivary Gland CancerTerminatedNCT00126607Phase 2
- Fulvestrant or Tamoxifen in Treating Postmenopausal Women Who Are Undergoing Surgery for Ductal Carcinoma in Situ of the BreastStatus unknownNCT00126464Not applicable
- Trial Comparing Cisplatin With or Without Gemcitabine in Patients With Carcinoma of Unknown PrimaryStatus unknownNCT00126269Phase 3
- Tumor Ablation With Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC)CompletedNCT00122876Phase 1/2
- A Study of Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck CancersStatus unknownNCT00122239
- Treatment of Hepatocellular Carcinoma: Long-Acting Somatostatin Plus Percutaneous Ethanol Instillation (PEI) Versus Long-Acting Somatostatin AloneStatus unknownNCT00121914Phase 3
- Gemcitabine, Docetaxel, and Capecitabine in Treating Patients With Cancer of Unknown Primary OriginWithdrawnNCT00119314Phase 2
- Lapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck CancerCompletedNCT00114283Phase 2
- Erlotinib and Docetaxel With Concomitant Boost Radiation Therapy (XRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)CompletedNCT00113347Phase 1
- GCSSG-SPNX: Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma: JCOG0110CompletedNCT00112099Phase 3
- Evaluating ABX-EGF in Patients With Metastatic ColorectalCarcinomaCompletedNCT00111774Phase 2
- Treatment Protocol for the Use of Sorafenib in Patients With Advanced Renal Cell CarcinomaCompletedNCT00111020Phase 3
- Research Study for Patients With Metastatic Renal Cell CarcinomaTerminatedNCT00110344Phase 2
- Dose-Escalation Study of CG0070 for Bladder Cancer After BCG (Bacillus Calmette-Guerin) FailureStatus unknownNCT00109655Phase 1
- Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Superficial Basal Cell CarcinomaCompletedNCT00108134Phase 2
- Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Nodular Basal Cell CarcinomaCompletedNCT00108121Phase 2
- Interferon-Beta Gene Transfer (Ad.hIFN-β) as Treatment for Refractory Colorectal Carcinoma With Liver MetastasesCompletedNCT00107861Phase 1/2
- EF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Cervical, Endometrial, or Ovarian Epithelial CancerCompletedNCT00107445Phase 2
- A Research Study for Patients With Metastatic Renal Cell CarcinomaCompletedNCT00106613Phase 2
- Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical CancerCompletedNCT00104910Phase 1
- A Study of Motexafin Gadolinium (MGd) in Combination With Docetaxel and Cisplatin for Treatment of Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00102505Phase 1
- Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the UrotheliumCompletedNCT00101608Phase 2
- Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung CancerCompletedNCT00101348Phase 1/2
- Study of M200 (Volociximab) in Patients With Metastatic Renal Cell Carcinoma (RCC)TerminatedNCT00100685Phase 2
- ARQ 501 in Combination With Docetaxel in Patients With CancerCompletedNCT00099190Phase 1
- Lapatinib in Treating Patients With Recurrent and/or Metastatic Head and Neck CancerCompletedNCT00098631Phase 2
- Sorafenib and Interferon Alfa in Treating Patients With Locally Advanced or Metastatic Kidney CancerTerminatedNCT00098618Phase 2
- Trial of Oral Karenitecin in Patients With Solid Tumors and Lung CancerCompletedNCT00097903Phase 1
- S0420, Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck CancerCompletedNCT00096512Phase 2
- S0225 Capecitabine in Treating Patients Who Have Undergone Surgery for Locally Recurrent or Persistent Head and Neck CancerWithdrawnNCT00095641Phase 2
- Safety/Efficacy Study of Oral Recombinant Human Lactoferrin in Renal Cell CarcinomaCompletedNCT00095186Phase 2
- Depsipeptide/Flavopiridol Infusion for Cancers of the Lungs, Esophagus, Pleura, Thymus or MediastinumTerminatedNCT00094978Phase 1
- Sorafenib in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Peritoneal CancerCompletedNCT00093626Phase 2
- Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous TreatmentCompletedNCT00091182Phase 2
- Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00089362Phase 1
- T4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney TransplantCompletedNCT00089180Phase 2
- RNA-Loaded Dendritic Cell Cancer VaccineCompletedNCT00087984Phase 1/2
- Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer)CompletedNCT00085358Phase 1
- Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)CompletedNCT00085332Phase 2
- Docetaxel and Carboplatin in Treating Patients With Recurrent Stage IVB Squamous Cell Carcinoma (Cancer) of the CervixTerminatedNCT00084890Phase 1
- Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the BladderWithdrawnNCT00084578Not applicable
- Fluorouracil and Low-Dose Suramin as Chemosensitization in Treating Patients With Metastatic Renal Cell (Kidney) CancerCompletedNCT00083109Phase 1/2
- Gefitinib, Paclitaxel, and Radiation Therapy in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and NeckCompletedNCT00083057Phase 1
- Gefitinib Followed By Surgery in Treating Women With Ductal Carcinoma In Situ of the BreastTerminatedNCT00082667Phase 2
- Trial to Compare the Routes of Administration of an Investigational, Personalized, Therapeutic Cancer Vaccine Oncophage (HSPPC-96) in Patients With Metastatic Renal Cell CarcinomaTerminatedNCT00082459Phase 2
- A Study in Patients With Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal CarcinomaTerminatedNCT00082212Phase 2
- A Trial of Thymalfasin in Adult Patients With Hepatocellular CarcinomaCompletedNCT00082082Phase 2
- A Safety and Efficacy Study of DENSPM in Patients With Liver Cancer Who Are Not Eligible for Surgical CareTerminatedNCT00081900Phase 1/2
- A Study Evaluating Tarceva in Combination With Avastin Versus Avastin Alone in Treating Metastatic Renal Cell CarcinomaCompletedNCT00081614Phase 2
- Intratumoral PV701 in Treating Patients With Advanced or Recurrent Unresectable Squamous Cell Carcinoma of the Head and NeckTerminatedNCT00081211Phase 1
- Positron Emission Tomography Using Carbon-11 Acetate and Fludeoxyglucose F 18 in Detecting Hepatocellular Carcinoma (Liver Cancer) in Patients With Known or Suspected Liver CancerCompletedNCT00081094Not applicable
- Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube CancerCompletedNCT00079430Phase 1
- Oblimersen in Treating Patients With Merkel Cell CarcinomaCompletedNCT00079131Phase 2
- Adjuvant Erlotinib After Completing Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and NeckCompletedNCT00079053Phase 1
- Doxorubicin By Infusion or Chemoembolization in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)Status unknownNCT00079027Phase 3
- Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell TransplantCompletedNCT00078858Phase 1/2
- EBV-Specific CTLs Following CD45 Antibody to Patients With Epstein-Barr Virus (EBV) + Nasopharyngeal Carcinoma (NPC)CompletedNCT00078546Phase 1
- Study of ILX651 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung CarcinomaCompletedNCT00078455Phase 2
- TOCOSOL(TM) Paclitaxel in Metastatic or Locally Advanced Unresectable Transitional Cell Carcinoma of the UrotheliumCompletedNCT00077688Phase 2